Maria Luisa Tamma

PET of Somatostatin Receptor–Positive Tumors Using ⁶⁴Cu- and ⁶⁸Ga-Somatostatin Antagonists: The Chelate Makes the Difference

Melpomeni Fani, Luigi Del Pozzo, K. Abiraj et al. · Journal of Nuclear Medicine · 2011 · 255 citations

The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model

Svetlana N. Rylova, C. Stoykow, Luigi Del Pozzo et al. · PLoS ONE · 2018 · 46 citations · Full text

Engineering, Imaging Agent, Pharmacotherapy +26

PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists

Mazen Jamous, Maria Luisa Tamma, Eleni Gourni et al. · Nuclear Medicine and Biology · 2014 · 45 citations

Different Length Influence, Medicine, Drug Discovery +6

Evaluation of Three Different Families of Bombesin Receptor Radioantagonists for Targeted Imaging and Therapy of Gastrin Releasing Peptide Receptor (GRP-R) Positive Tumors

Rosalba Mansi, K. Abiraj, Xuejuan Wang et al. · Journal of Medicinal Chemistry · 2014 · 24 citations

Engineering, Pharmacotherapy, Chemical Biology +22

The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist

K. Abiraj, Samer Ursillo, Maria Luisa Tamma et al. · EJNMMI Research · 2018 · 19 citations · Full text